Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in patients with gastrointestinal side effects: Case studies

Progress in Transplantation

Volumn 16, Issue 2, 2006, Pages 138-140

  Boswell, Anita ^a   Rigg, Keith ^a   Shehata, Magdi ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; ENTERIC COATED TABLET; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

ADULT; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TABLETS, ENTERIC-COATED;

EID: 33746700882     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/prtr.16.2.48v85j24052q6430     Document Type: Article

References (8)

1. Helderman J. Prophylaxis and treatment of gastrointestinal complications following transplantation. Clin Transplant. 2001;15 (suppl 4):29-35. (Pubitemid 32509966)
2. Behrend M. Adverse gastrointestinal effects of mycophenolate mofetil, aetiology, incidences and management. Drug Safety. 2001;24:645-663. (Pubitemid 32761719)
3. Pelletier R, Akin B, Henry M, Bumgardner G, Elkhammas A, Ferguson R. The impact of Mycophenolate Mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant. 2003;17:200-205. (Pubitemid 36748465)
4. Hardinger K, Brennan D, Lowell J, Schnitzler M. Long-term outcome of gastrointestinal complications in renal transplant patients treated with Mycophenolate Mofetil. Transpl Int. 2004;17:609-616 (Pubitemid 40104663)
5. Salvadori M, Holzer H, de Mattos A, et al. Enteric-coated Mycophenolate Sodium is therapeutically equivalent to MMF in de novo renal transplant patients. Am J Transplant. 2004; 4:231-236. (Pubitemid 38248526)
6. Granger DK. Enteric-coated Mycophenolate sodium: results of two pivotal global multicentre trials. Transplant Proc. 2001;33:3241-3244. (Pubitemid 34042557)
7. Budde K, Curtis J, Knoll G, Chan L, Neumayer H, Seifu Y. Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study. Am J Transplant. 2004;4:237-243. (Pubitemid 38248527)
8. Dimenas E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol. 1996;221 (suppl):8-13. (Pubitemid 27023576)